speb/financial-data huggingface dataset:
CHRD cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -533000.00
CHRD income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -80150000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -26826000.00
CHRD cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -51514000.00
CHRD cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -7533000.00
CHRD cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 25000000.00
CHRD cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 55000000.00
CHRD balance_sheet (annual, 2025-12-31) — Net PPE: 11349278000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Net PPE: 11349278000.00
CHRD balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 8079954000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 8079954000.00
CHRD balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1615850000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1615850000.00
CHRD balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1615850000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1615850000.00
CHRD income_statement (annual, 2025-12-31) — Normalized EBITDA: 1660970000.00
CHRD income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 462120000.00
CHRD income_statement (annual, 2025-12-31) — Normalized Income: -60480650.00
CHRD income_statement (quarterly, 2025-12-31) — Normalized Income: 48699380.95
CHRD cash_flow (annual, 2025-12-31) — Operating Cash Flow: 2040657000.00
CHRD cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 404987000.00
CHRD cash_flow (annual, 2025-12-31) — Operating Gains Losses: -119878000.00
CHRD cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -46577000.00
CHRD income_statement (annual, 2025-12-31) — Operating Income: 188714000.00
CHRD income_statement (quarterly, 2025-12-31) — Operating Income: 87774000.00
CHRD income_statement (annual, 2025-12-31) — Operating Revenue: 4877126000.00
CHRD income_statement (quarterly, 2025-12-31) — Operating Revenue: 1169439000.00
CHRD balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 56762243.00
CHRD balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 56762243.00
CHRD balance_sheet (annual, 2025-12-31) — Other Current Assets: 5061000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 5061000.00
CHRD balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 11898000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 11898000.00
CHRD income_statement (annual, 2025-12-31) — Other Gand A: 126294000.00
CHRD income_statement (quarterly, 2025-12-31) — Other Gand A: 33516000.00
CHRD income_statement (annual, 2025-12-31) — Other Income Expense: 134920000.00
CHRD income_statement (quarterly, 2025-12-31) — Other Income Expense: 54927000.00
CHRD cash_flow (annual, 2025-12-31) — Other Non Cash Items: -31318000.00
CHRD cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -12036000.00
CHRD balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 58863000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 58863000.00
CHRD balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 4982000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4982000.00
CHRD income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 15042000.00
CHRD income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 8350000.00
CHRD income_statement (annual, 2025-12-31) — Other Operating Expenses: 551412000.00
CHRD income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 5455000.00
CHRD balance_sheet (annual, 2025-12-31) — Other Payable: 583475000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Other Payable: 583475000.00
CHRD balance_sheet (annual, 2025-12-31) — Other Properties: 73144000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Other Properties: 73144000.00
CHRD income_statement (annual, 2025-12-31) — Other Special Charges: 3494000.00
CHRD income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
CHRD income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 1736000.00
CHRD income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 423000.00
CHRD balance_sheet (annual, 2025-12-31) — Payables: 660912000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Payables: 660912000.00
CHRD balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1253610000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1253610000.00
CHRD balance_sheet (annual, 2025-12-31) — Prepaid Assets: 33767000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 33767000.00
CHRD income_statement (annual, 2025-12-31) — Pretax Income: 243484000.00
CHRD income_statement (quarterly, 2025-12-31) — Pretax Income: 115875000.00
CHRD cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 408000.00
CHRD cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 385000.00
CHRD cash_flow (annual, 2025-12-31) — Purchase Of Business: -575668000.00
CHRD cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -548234000.00
CHRD balance_sheet (annual, 2025-12-31) — Raw Materials: 115713000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Raw Materials: 115713000.00
CHRD balance_sheet (annual, 2025-12-31) — Receivables: 1116685000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Receivables: 1116685000.00
CHRD balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -11543000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -11543000.00
CHRD income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4010706000.00
CHRD income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1042694000.00
CHRD income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1470171000.00
CHRD income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 368446000.00
CHRD cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4674349000.00
CHRD cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -139533000.00
CHRD cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -364877000.00
CHRD cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -7040000.00
CHRD balance_sheet (annual, 2025-12-31) — Retained Earnings: 2043636000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 2043636000.00
CHRD cash_flow (annual, 2025-12-31) — Sale Of Business: 24762000.00
CHRD cash_flow (quarterly, 2025-12-31) — Sale Of Business: 14027000.00
CHRD income_statement (annual, 2025-12-31) — Selling General And Administration: 126294000.00
CHRD income_statement (quarterly, 2025-12-31) — Selling General And Administration: 33516000.00
CHRD balance_sheet (annual, 2025-12-31) — Share Issued: 67150747.00
CHRD balance_sheet (quarterly, 2025-12-31) — Share Issued: 67150747.00
CHRD income_statement (annual, 2025-12-31) — Special Income Charges: 5217000.00
CHRD income_statement (quarterly, 2025-12-31) — Special Income Charges: 4083000.00
CHRD cash_flow (annual, 2025-12-31) — Stock Based Compensation: 25703000.00
CHRD cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6239000.00
CHRD balance_sheet (annual, 2025-12-31) — Stockholders Equity: 8079954000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 8079954000.00
CHRD balance_sheet (annual, 2025-12-31) — Tangible Book Value: 8079954000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 8079954000.00
CHRD income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 27895350.00
CHRD income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 13310380.95
CHRD income_statement (annual, 2025-12-31) — Tax Provision: 199025000.00
CHRD income_statement (quarterly, 2025-12-31) — Tax Provision: 31459000.00
CHRD income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CHRD income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
CHRD balance_sheet (annual, 2025-12-31) — Total Assets: 13074274000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Assets: 13074274000.00
CHRD balance_sheet (annual, 2025-12-31) — Total Capitalization: 9559535000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 9559535000.00
CHRD balance_sheet (annual, 2025-12-31) — Total Debt: 1626061000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Debt: 1626061000.00
CHRD balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 8079954000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 8079954000.00
CHRD income_statement (annual, 2025-12-31) — Total Expenses: 4688412000.00
CHRD income_statement (quarterly, 2025-12-31) — Total Expenses: 1081665000.00
CHRD balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4994320000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4994320000.00
CHRD balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 11536205000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 11536205000.00
CHRD balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3543733000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3543733000.00
CHRD income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 197425000.00
CHRD income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 91857000.00
CHRD balance_sheet (annual, 2025-12-31) — Total Tax Payable: 34783000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 34783000.00
CHRD income_statement (annual, 2025-12-31) — Total Unusual Items: 132835000.00
CHRD income_statement (quarterly, 2025-12-31) — Total Unusual Items: 49027000.00
CHRD income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 132835000.00
CHRD income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 49027000.00
CHRD balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 10388504.00
CHRD balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 10388504.00
CHRD balance_sheet (annual, 2025-12-31) — Treasury Stock: 1304092000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 1304092000.00
CHRD balance_sheet (annual, 2025-12-31) — Working Capital: 87482000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Working Capital: 87482000.00
CHRD income_statement (quarterly, 2026-03-31) — +Operating Expense: 40071000.00
CHRD income_statement (quarterly, 2026-03-31) — +Total Revenue: 1665635000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 90764000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1128597000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3950750000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 7343454000.00
CHRD income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 0.00
CHRD income_statement (quarterly, 2026-03-31) — Basic Average Shares: 56717000.00
CHRD income_statement (quarterly, 2026-03-31) — Basic EPS: 1.90
CHRD cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 189531000.00
CHRD cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -351284000.00
CHRD cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -351284000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 134921000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Capital Stock: 676000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 225802000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 225802000.00
CHRD cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -74184000.00
CHRD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -146791000.00
CHRD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -324405000.00
CHRD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 507467000.00
CHRD cash_flow (quarterly, 2026-03-31) — Change In Inventory: 14980000.00
CHRD cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -2168000.00
CHRD cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 81698000.00
CHRD cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 4630000.00
CHRD cash_flow (quarterly, 2026-03-31) — Change In Receivables: -264809000.00
CHRD cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -165669000.00
CHRD cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -264809000.00
CHRD cash_flow (quarterly, 2026-03-31) — Changes In Cash: 36271000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Common Stock: 676000.00
CHRD cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -74184000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 8046347000.00
CHRD cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -67738000.00
CHRD income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1292685000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 524945000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Current Assets: 1713636000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 125356000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 125356000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1673114000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Current Provisions: 50534000.00
CHRD cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -33128000.00
CHRD cash_flow (quarterly, 2026-03-31) — Deferred Tax: -33128000.00
CHRD cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 384215000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 10204000.00
CHRD income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 56774000.00
CHRD income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.90
CHRD income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 107766000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 932000.00
CHRD cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 2432000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 238025000.00
CHRD income_statement (quarterly, 2026-03-31) — EBIT: 120909000.00
CHRD income_statement (quarterly, 2026-03-31) — EBITDA: 505124000.00
CHRD income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 22829000.00
CHRD cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -22829000.00
CHRD cash_flow (quarterly, 2026-03-31) — End Cash Position: 225802000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Financial Assets: 3518000.00
CHRD cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -146791000.00
CHRD cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 156183000.00
CHRD cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 241471000.00
CHRD income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 343000.00
CHRD income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -241471000.00
CHRD income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 37508000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Gross PPE: 15275038000.00
CHRD income_statement (quarterly, 2026-03-31) — Gross Profit: 372950000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 1161000.00
CHRD income_statement (quarterly, 2026-03-31) — Interest Expense: 26596000.00
CHRD income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 26596000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Interest Payable: 4301000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Inventory: 100218000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Invested Capital: 9526816000.00
CHRD cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -324405000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 140096000.00
CHRD cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 5000000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 9565000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1480469000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1490034000.00
CHRD cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 5000000.00
CHRD cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -5546000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 140096000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 428773000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -4652000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -67738000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Net Debt: 1254667000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Income: 108608000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 107766000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 108608000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 108608000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 108608000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 108608000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 108608000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Interest Income: -26596000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 4099000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -546000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -546000.00
CHRD income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -26596000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -4323000.00
CHRD cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 25000000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Net PPE: 11324288000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 8046347000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1582722000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1582722000.00
CHRD income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 746252000.00
CHRD income_statement (quarterly, 2026-03-31) — Normalized Income: 253284800.00
CHRD cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 507467000.00
CHRD cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 218299000.00
CHRD income_statement (quarterly, 2026-03-31) — Operating Income: 332879000.00
CHRD income_statement (quarterly, 2026-03-31) — Operating Revenue: 1665635000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 56284329.00
CHRD balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3683000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 164489000.00
CHRD income_statement (quarterly, 2026-03-31) — Other Gand A: 37508000.00
CHRD income_statement (quarterly, 2026-03-31) — Other Income Expense: -211970000.00
CHRD cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -12900000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 55316000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 5660000.00
CHRD income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 6329000.00
CHRD income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2563000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Other Payable: 658827000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Other Properties: 69476000.00
CHRD income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 842000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Payables: 807790000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1332735000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 30226000.00
CHRD income_statement (quarterly, 2026-03-31) — Pretax Income: 94313000.00
CHRD cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -4978000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Raw Materials: 100218000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Receivables: 1352546000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -14076000.00
CHRD income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1292685000.00
CHRD income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 384215000.00
CHRD cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -5546000.00
CHRD cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -67738000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2077673000.00
CHRD cash_flow (quarterly, 2026-03-31) — Sale Of Business: 326000.00
CHRD cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 4099000.00
CHRD income_statement (quarterly, 2026-03-31) — Selling General And Administration: 37508000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Share Issued: 67231897.00
CHRD income_statement (quarterly, 2026-03-31) — Special Income Charges: 343000.00
CHRD cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8042000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 8046347000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 8046347000.00
CHRD income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -96451200.00
CHRD income_statement (quarterly, 2026-03-31) — Tax Provision: -14295000.00
CHRD income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CHRD balance_sheet (quarterly, 2026-03-31) — Total Assets: 13236854000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 9526816000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Total Debt: 1615390000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 8046347000.00
CHRD income_statement (quarterly, 2026-03-31) — Total Expenses: 1332756000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5190507000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 11523218000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3517393000.00
CHRD income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 333222000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 57267000.00
CHRD income_statement (quarterly, 2026-03-31) — Total Unusual Items: -241128000.00
CHRD income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -241128000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 10947568.00
CHRD balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 1375456000.00
CHRD balance_sheet (quarterly, 2026-03-31) — Working Capital: 40522000.00
CHRN income_statement (annual, 2025-05-31) — +Operating Expense: 26700000.00
CHRN income_statement (annual, 2025-05-31) — +Total Revenue: 84376000.00
CHRN balance_sheet (annual, 2025-05-31) — Accounts Payable: 3962000.00
CHRN balance_sheet (annual, 2025-05-31) — Accounts Receivable: 3788000.00
CHRN balance_sheet (annual, 2025-05-31) — Accumulated Depreciation: -2678000.00
CHRN cash_flow (annual, 2025-05-31) — Amortization Cash Flow: 78724000.00
CHRN cash_flow (annual, 2025-05-31) — Amortization Of Intangibles: 78724000.00
CHRN cash_flow (annual, 2025-05-31) — Asset Impairment Charge: -414000.00
CHRN cash_flow (annual, 2025-05-31) — Beginning Cash Position: 0.00
CHRN cash_flow (annual, 2025-05-31) — Capital Expenditure: -1376000.00
CHRN balance_sheet (annual, 2025-05-31) — Capital Lease Obligations: 207920000.00
CHRN balance_sheet (annual, 2025-05-31) — Cash And Cash Equivalents: 2398000.00
CHRN balance_sheet (annual, 2025-05-31) — Cash Cash Equivalents And Short Term Investments: 2398000.00
CHRN balance_sheet (annual, 2025-05-31) — Cash Financial: 2398000.00
CHRN cash_flow (annual, 2025-05-31) — Cash Flow From Continuing Financing Activities: 10996000.00
CHRN cash_flow (annual, 2025-05-31) — Cash Flow From Continuing Investing Activities: -1376000.00
CHRN cash_flow (annual, 2025-05-31) — Cash Flow From Continuing Operating Activities: -7222000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Account Payable: -9014000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Accrued Expense: -1008000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Other Current Assets: 581000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Other Working Capital: -31075000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Payable: -9014000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Payables And Accrued Expense: -10022000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Prepaid Assets: 111000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Receivables: -3788000.00
CHRN cash_flow (annual, 2025-05-31) — Change In Working Capital: -44193000.00
CHRN cash_flow (annual, 2025-05-31) — Changes In Account Receivables: -3788000.00
CHRN cash_flow (annual, 2025-05-31) — Changes In Cash: 2398000.00
CHRN balance_sheet (annual, 2025-05-31) — Common Stock Equity: 76152000.00
CHRN balance_sheet (annual, 2025-05-31) — Construction In Progress: 3331000.00
CHRN income_statement (annual, 2025-05-31) — Cost Of Revenue: 115300000.00
CHRN balance_sheet (annual, 2025-05-31) — Current Accrued Expenses: 572000.00
CHRN balance_sheet (annual, 2025-05-31) — Current Assets: 6409000.00
CHRN balance_sheet (annual, 2025-05-31) — Current Capital Lease Obligation: 149500000.00
CHRN balance_sheet (annual, 2025-05-31) — Current Debt And Capital Lease Obligation: 149500000.00
CHRN balance_sheet (annual, 2025-05-31) — Current Deferred Liabilities: 3594000.00
CHRN balance_sheet (annual, 2025-05-31) — Current Deferred Revenue: 3594000.00
CHRN balance_sheet (annual, 2025-05-31) — Current Liabilities: 157628000.00
CHRN cash_flow (annual, 2025-05-31) — Depreciation: 80624000.00
CHRN cash_flow (annual, 2025-05-31) — Depreciation Amortization Depletion: 80656000.00
CHRN income_statement (annual, 2025-05-31) — Depreciation Amortization Depletion Income Statement: 1000000.00
CHRN cash_flow (annual, 2025-05-31) — Depreciation And Amortization: 80656000.00
CHRN income_statement (annual, 2025-05-31) — Depreciation And Amortization In Income Statement: 1000000.00
CHRN income_statement (annual, 2025-05-31) — Diluted NI Availto Com Stockholders: -72730000.00
CHRN income_statement (annual, 2025-05-31) — EBIT: -55331000.00
CHRN income_statement (annual, 2025-05-31) — EBITDA: 25325000.00
CHRN cash_flow (annual, 2025-05-31) — End Cash Position: 2398000.00
CHRN cash_flow (annual, 2025-05-31) — Financing Cash Flow: 10996000.00
CHRN cash_flow (annual, 2025-05-31) — Free Cash Flow: -8598000.00
CHRN income_statement (annual, 2025-05-31) — General And Administrative Expense: 16200000.00
CHRN balance_sheet (annual, 2025-05-31) — Gross PPE: 300469000.00
CHRN income_statement (annual, 2025-05-31) — Gross Profit: -30924000.00
CHRN income_statement (annual, 2025-05-31) — Interest Expense: 17399000.00
CHRN income_statement (annual, 2025-05-31) — Interest Expense Non Operating: 17399000.00
CHRN cash_flow (annual, 2025-05-31) — Interest Paid Supplemental Data: 17270000.00
CHRN balance_sheet (annual, 2025-05-31) — Invested Capital: 88152000.00
CHRN cash_flow (annual, 2025-05-31) — Investing Cash Flow: -1376000.00
CHRN cash_flow (annual, 2025-05-31) — Issuance Of Debt: 12000000.00
CHRN balance_sheet (annual, 2025-05-31) — Leases: 697000.00
CHRN balance_sheet (annual, 2025-05-31) — Long Term Capital Lease Obligation: 58420000.00
CHRN balance_sheet (annual, 2025-05-31) — Long Term Debt: 12000000.00
CHRN balance_sheet (annual, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 70420000.00
CHRN cash_flow (annual, 2025-05-31) — Long Term Debt Issuance: 12000000.00
CHRN cash_flow (annual, 2025-05-31) — Long Term Debt Payments: -114743000.00
CHRN balance_sheet (annual, 2025-05-31) — Machinery Furniture Equipment: 9572000.00
CHRN balance_sheet (annual, 2025-05-31) — Net Debt: 9602000.00
CHRN income_statement (annual, 2025-05-31) — Net Income: -72730000.00
CHRN income_statement (annual, 2025-05-31) — Net Income Common Stockholders: -72730000.00
CHRN income_statement (annual, 2025-05-31) — Net Income Continuous Operations: -72730000.00
CHRN income_statement (annual, 2025-05-31) — Net Income From Continuing And Discontinued Operation: -72730000.00
CHRN income_statement (annual, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: -72730000.00
CHRN cash_flow (annual, 2025-05-31) — Net Income From Continuing Operations: -72730000.00
CHRN income_statement (annual, 2025-05-31) — Net Income Including Noncontrolling Interests: -72730000.00
CHRN income_statement (annual, 2025-05-31) — Net Interest Income: -17399000.00
CHRN cash_flow (annual, 2025-05-31) — Net Issuance Payments Of Debt: -102743000.00
CHRN cash_flow (annual, 2025-05-31) — Net Long Term Debt Issuance: -102743000.00
CHRN income_statement (annual, 2025-05-31) — Net Non Operating Interest Income Expense: -17399000.00
CHRN cash_flow (annual, 2025-05-31) — Net Other Financing Charges: 113739000.00
CHRN balance_sheet (annual, 2025-05-31) — Net PPE: 297791000.00
CHRN cash_flow (annual, 2025-05-31) — Net PPE Purchase And Sale: -1376000.00
CHRN balance_sheet (annual, 2025-05-31) — Net Tangible Assets: 76152000.00
CHRN income_statement (annual, 2025-05-31) — Normalized EBITDA: 24911000.00
CHRN income_statement (annual, 2025-05-31) — Normalized Income: -73144000.00
CHRN cash_flow (annual, 2025-05-31) — Operating Cash Flow: -7222000.00
CHRN income_statement (annual, 2025-05-31) — Operating Income: -57624000.00
CHRN income_statement (annual, 2025-05-31) — Operating Revenue: 84376000.00
CHRN balance_sheet (annual, 2025-05-31) — Ordinary Shares Number: 143093381.00
CHRN balance_sheet (annual, 2025-05-31) — Other Current Assets: 223000.00
CHRN balance_sheet (annual, 2025-05-31) — Other Equity Interest: 76152000.00
CHRN income_statement (annual, 2025-05-31) — Other Gand A: 900000.00
CHRN income_statement (annual, 2025-05-31) — Other Income Expense: 414000.00
CHRN cash_flow (annual, 2025-05-31) — Other Non Cash Items: 30508000.00
CHRN balance_sheet (annual, 2025-05-31) — Other Properties: 286869000.00
CHRN income_statement (annual, 2025-05-31) — Other Special Charges: -414000.00
CHRN balance_sheet (annual, 2025-05-31) — Payables: 3962000.00
CHRN balance_sheet (annual, 2025-05-31) — Payables And Accrued Expenses: 4534000.00
CHRN income_statement (annual, 2025-05-31) — Pretax Income: -72730000.00
CHRN balance_sheet (annual, 2025-05-31) — Properties: 0.00
CHRN income_statement (annual, 2025-05-31) — Provision For Doubtful Accounts: 9500000.00
CHRN cash_flow (annual, 2025-05-31) — Purchase Of PPE: -1376000.00
CHRN balance_sheet (annual, 2025-05-31) — Receivables: 3788000.00
CHRN income_statement (annual, 2025-05-31) — Reconciled Cost Of Revenue: 35644000.00
CHRN income_statement (annual, 2025-05-31) — Reconciled Depreciation: 80656000.00
CHRN income_statement (annual, 2025-05-31) — Rent And Landing Fees: 14800000.00
CHRN income_statement (annual, 2025-05-31) — Rent Expense Supplemental: 38600000.00
CHRN cash_flow (annual, 2025-05-31) — Repayment Of Debt: -114743000.00
CHRN income_statement (annual, 2025-05-31) — Salaries And Wages: 500000.00
CHRN income_statement (annual, 2025-05-31) — Selling General And Administration: 16200000.00
CHRN balance_sheet (annual, 2025-05-31) — Share Issued: 143093381.00
CHRN income_statement (annual, 2025-05-31) — Special Income Charges: 414000.00
CHRN cash_flow (annual, 2025-05-31) — Stock Based Compensation: -1463000.00
CHRN balance_sheet (annual, 2025-05-31) — Stockholders Equity: 76152000.00
CHRN balance_sheet (annual, 2025-05-31) — Tangible Book Value: 76152000.00
CHRN income_statement (annual, 2025-05-31) — Tax Effect Of Unusual Items: 0.00
CHRN income_statement (annual, 2025-05-31) — Tax Provision: 0.00
CHRN income_statement (annual, 2025-05-31) — Tax Rate For Calcs: 0.00
CHRN balance_sheet (annual, 2025-05-31) — Total Assets: 304200000.00
CHRN balance_sheet (annual, 2025-05-31) — Total Capitalization: 88152000.00
CHRN balance_sheet (annual, 2025-05-31) — Total Debt: 219920000.00
CHRN balance_sheet (annual, 2025-05-31) — Total Equity Gross Minority Interest: 76152000.00
CHRN income_statement (annual, 2025-05-31) — Total Expenses: 142000000.00
CHRN balance_sheet (annual, 2025-05-31) — Total Liabilities Net Minority Interest: 228048000.00
CHRN balance_sheet (annual, 2025-05-31) — Total Non Current Assets: 297791000.00
CHRN balance_sheet (annual, 2025-05-31) — Total Non Current Liabilities Net Minority Interest: 70420000.00
CHRN income_statement (annual, 2025-05-31) — Total Operating Income As Reported: -55331000.00
CHRN income_statement (annual, 2025-05-31) — Total Unusual Items: 414000.00
CHRN income_statement (annual, 2025-05-31) — Total Unusual Items Excluding Goodwill: 414000.00
CHRN balance_sheet (annual, 2025-05-31) — Working Capital: -151219000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 3182000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Accounts Receivable: 9031000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Accumulated Depreciation: -3730000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Capital Lease Obligations: 156450000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 2000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 2000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Cash Financial: 2000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 98481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Construction In Progress: 9203000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Current Accrued Expenses: 1534000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Current Assets: 9593000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Current Capital Lease Obligation: 91884000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Current Debt And Capital Lease Obligation: 91884000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Current Deferred Liabilities: 152000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Current Deferred Revenue: 152000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 96752000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Gross PPE: 265936000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Invested Capital: 110481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Leases: 697000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Long Term Capital Lease Obligation: 64566000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Long Term Debt: 12000000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 76566000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Machinery Furniture Equipment: 9527000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Net Debt: 11998000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Net PPE: 262206000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 98481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 143093381.00
CHRN balance_sheet (quarterly, 2025-11-30) — Other Current Assets: 560000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Other Equity Interest: 98481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Other Properties: 246509000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Payables: 3182000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 4716000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Properties: 0.00
CHRN balance_sheet (quarterly, 2025-11-30) — Receivables: 9031000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Share Issued: 143093381.00
CHRN balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 98481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 98481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Total Assets: 271799000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 110481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Total Debt: 168450000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 98481000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 173318000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 262206000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 76566000.00
CHRN balance_sheet (quarterly, 2025-11-30) — Working Capital: -87159000.00
CHRS cash_flow (annual, 2021-12-31) — Amortization Of Securities: 1095000.00
CHRS income_statement (annual, 2021-12-31) — Average Dilution Earnings: 0.00
CHRS income_statement (annual, 2021-12-31) — Basic Average Shares: 75449632.00
CHRS income_statement (annual, 2021-12-31) — Basic EPS: -3.81
CHRS cash_flow (annual, 2021-12-31) — Capital Expenditure: -1289000.00
CHRS cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -230000.00
CHRS balance_sheet (annual, 2021-12-31) — Construction In Progress: 388000.00
CHRS income_statement (annual, 2021-12-31) — Diluted Average Shares: 75449632.00
CHRS income_statement (annual, 2021-12-31) — Diluted EPS: -3.81
CHRS cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: 0.00
CHRS balance_sheet (annual, 2021-12-31) — Goodwill: 943000.00
CHRS cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 1221000.00
CHRS cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
CHRS cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
CHRS cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -1289000.00
CHRS balance_sheet (annual, 2021-12-31) — Other Properties: 2294000.00
CHRS cash_flow (annual, 2021-12-31) — Purchase Of PPE: -1289000.00
CHRS cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
CHRS income_statement (annual, 2022-12-31) — +Operating Expense: 397839000.00
CHRS income_statement (annual, 2022-12-31) — +Total Revenue: 211042000.00
CHRS balance_sheet (annual, 2022-12-31) — Accounts Payable: 11526000.00
CHRS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 109964000.00
CHRS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -20157000.00
CHRS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1204431000.00
CHRS cash_flow (annual, 2022-12-31) — Amortization Of Securities: -730000.00
CHRS cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 26000000.00
CHRS income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
CHRS income_statement (annual, 2022-12-31) — Basic Average Shares: 77630020.00
CHRS income_statement (annual, 2022-12-31) — Basic EPS: -3.76
CHRS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 417635000.00
CHRS cash_flow (annual, 2022-12-31) — Capital Expenditure: -2039000.00
CHRS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 9364000.00
CHRS balance_sheet (annual, 2022-12-31) — Capital Stock: 8000.00
CHRS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 63547000.00
CHRS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 191681000.00
CHRS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 54326000.00
CHRS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -166850000.00
CHRS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -241124000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Account Payable: -4548000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -22775000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Inventory: -47348000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 596000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Payable: -4548000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -27323000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -17638000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Receivables: 13052000.00
CHRS cash_flow (annual, 2022-12-31) — Change In Working Capital: -79257000.00
CHRS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 13052000.00
CHRS cash_flow (annual, 2022-12-31) — Changes In Cash: -353648000.00
CHRS balance_sheet (annual, 2022-12-31) — Common Stock: 8000.00
CHRS balance_sheet (annual, 2022-12-31) — Common Stock Equity: -137418000.00
CHRS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 6358000.00
CHRS balance_sheet (annual, 2022-12-31) — Construction In Progress: 696000.00
CHRS income_statement (annual, 2022-12-31) — Cost Of Revenue: 70083000.00
CHRS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 100240000.00
CHRS balance_sheet (annual, 2022-12-31) — Current Assets: 381234000.00
CHRS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 4318000.00
CHRS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 4318000.00
CHRS balance_sheet (annual, 2022-12-31) — Current Liabilities: 138694000.00
CHRS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3699000.00
CHRS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3699000.00
CHRS income_statement (annual, 2022-12-31) — Diluted Average Shares: 77630020.00
CHRS income_statement (annual, 2022-12-31) — Diluted EPS: -3.76
CHRS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -291754000.00
CHRS income_statement (annual, 2022-12-31) — EBIT: -259280000.00
CHRS income_statement (annual, 2022-12-31) — EBITDA: -255581000.00
CHRS cash_flow (annual, 2022-12-31) — End Cash Position: 63987000.00
CHRS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 54326000.00
CHRS cash_flow (annual, 2022-12-31) — Free Cash Flow: -241124000.00
CHRS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 35000000.00
CHRS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CHRS income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
CHRS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -249000.00
CHRS balance_sheet (annual, 2022-12-31) — Goodwill: 943000.00
CHRS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 5931000.00
CHRS balance_sheet (annual, 2022-12-31) — Gross PPE: 28911000.00
CHRS income_statement (annual, 2022-12-31) — Gross Profit: 140959000.00
CHRS cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 40000.00
CHRS income_statement (annual, 2022-12-31) — Interest Expense: 32474000.00
CHRS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 32474000.00
CHRS cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 34878000.00
CHRS balance_sheet (annual, 2022-12-31) — Inventory: 38791000.00
CHRS balance_sheet (annual, 2022-12-31) — Invested Capital: 333640000.00
CHRS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -166850000.00
CHRS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 6358000.00
CHRS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 240679000.00
CHRS balance_sheet (annual, 2022-12-31) — Leases: 6198000.00
CHRS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 5046000.00
CHRS balance_sheet (annual, 2022-12-31) — Long Term Debt: 471058000.00
CHRS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 476104000.00
CHRS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 240679000.00
CHRS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -190750000.00
CHRS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 17385000.00
CHRS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -35000000.00
CHRS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 6358000.00
CHRS balance_sheet (annual, 2022-12-31) — Net Debt: 407511000.00
CHRS income_statement (annual, 2022-12-31) — Net Income: -291754000.00
CHRS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -291754000.00
CHRS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -291754000.00
CHRS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -291754000.00
CHRS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -291754000.00
CHRS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -291754000.00
CHRS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -291754000.00
CHRS income_statement (annual, 2022-12-31) — Net Interest Income: -32474000.00
CHRS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -127382000.00
CHRS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 49929000.00
CHRS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 49929000.00
CHRS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -32474000.00
CHRS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -4972000.00
CHRS cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -4468000.00
CHRS balance_sheet (annual, 2022-12-31) — Net PPE: 8754000.00
CHRS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2039000.00
CHRS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -143349000.00
CHRS balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 0.00
CHRS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CHRS income_statement (annual, 2022-12-31) — Normalized EBITDA: -249359000.00
CHRS income_statement (annual, 2022-12-31) — Normalized Income: -285532000.00
CHRS cash_flow (annual, 2022-12-31) — Operating Cash Flow: -241124000.00
CHRS cash_flow (annual, 2022-12-31) — Operating Gains Losses: 41222000.00
CHRS income_statement (annual, 2022-12-31) — Operating Income: -256880000.00
CHRS income_statement (annual, 2022-12-31) — Operating Revenue: 211042000.00
CHRS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 78851516.00
CHRS balance_sheet (annual, 2022-12-31) — Other Current Assets: 22918000.00
CHRS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -249000.00
CHRS income_statement (annual, 2022-12-31) — Other Income Expense: -2400000.00
CHRS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4988000.00
CHRS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 8229000.00
CHRS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 84928000.00
CHRS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 3467000.00
CHRS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 3822000.00
CHRS balance_sheet (annual, 2022-12-31) — Other Properties: 4632000.00
CHRS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 128134000.00
CHRS income_statement (annual, 2022-12-31) — Other Special Charges: 6222000.00
CHRS balance_sheet (annual, 2022-12-31) — Payables: 11526000.00
CHRS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 111766000.00
CHRS balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 22610000.00
CHRS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CHRS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 17880000.00
CHRS income_statement (annual, 2022-12-31) — Pretax Income: -291754000.00
CHRS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3011000.00
CHRS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CHRS cash_flow (annual, 2022-12-31) — Purchase Of Business: -35000000.00
CHRS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -127382000.00
CHRS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2039000.00
CHRS balance_sheet (annual, 2022-12-31) — Receivables: 109964000.00
CHRS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 70083000.00